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Most previous longitudinal studies of functional magnetic resonance imaging (fMRI)
in first-episode psychosis (FEP) using cognitive paradigm task found an increased
activation after antipsychotic medications. We designed an emotional auditory paradigm
to explore brain activation during emotional and nonemotional word processing. This
study aimed to analyze if longitudinal changes in brain fMRI BOLD activation is present
in patients vs. healthy controls. A group of FEP patients (n = 34) received clinical
assessment and had a fMRI scan at baseline and follow-up (average, 25-month interval).
During the fMRI scan, both emotional and nonemotional words were presented as a block
design. Results were compared with a pair of healthy control group (n = 13). Patients
showed a decreased activation at follow-up fMRI in amygdala (F = 4.69; p = 0.04)
and hippocampus (F = 5.03; p = 0.03) compared with controls. Middle frontal gyrus
was the only area that showed a substantial increased activation in patients (F = 4.53;
p = 0.04). A great heterogeneity in individual activation patterns was also found. These
results support the relevance of the type of paradigm in neuroimaging for psychosis. This
is, as far as we know, the first longitudinal study with an emotional auditory paradigm
in FEP. Our results suggested that the amygdala and hippocampus play a key role in
psychotic disease. More studies are needed to understand the heterogeneity of response
at individual level.
Keywords: first episode psychosis (FEP), fMRI—functional magnetic resonance imaging, longitudinal, emotional
design model, paradigm, follow up
INTRODUCTION
Psychosis is a group of heterogeneous mental disorders characterized by important life
disturbances, cognitive impairment, interpersonal problems, and, finally, high economic costs for
health systems, including indirect costs such as unemployment and social support, and direct
costs from hospitalizations during crises (1). First-episode psychosis (FEP) is defined as the first
manifestation of a psychotic disorder meeting appropriate diagnostic symptom and time criteria
(2), occurring in more than 3% of people at some point in life (3).
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FEP has received a lot of interest from the scientific
community in recent years, to increase recovery rates and prevent
deterioration due to the emerging importance of an adequate and
rapid response in the early stages of the disease (4–8). Prodromal
factors have been investigated, conforming the clinical high-risk
state for psychosis (CHR-P) knowledge based on two decades (9),
seeking to clarify the most important risk factors that can predict
the emerging of first symptom and answer why most high-risk
individuals will never develop symptoms while being exposed
to these risk factors, although meta-analyses report around 30%
of high-risk individuals developing symptoms (1). In that sense,
genetic and environmental interaction should also be considered,
as they seem to work synergistically (6). In this sense, a great
heterogeneity has been described within the CHR-P population,
finding different subgroups prior to the emerging of FEP (10).
Despite this research effort, there are key remaining questions
regarding FEP, the factors that explain the enormous clinical
heterogeneity, the different course trajectories, and high relapse
risks after improving pharmacological treatments and early
interventions (6).
One main attempt to evaluate FEP is by using neuroimaging
techniques. Most publications use MRI imaging measurements
(11), ventricular dilation, and gray matter lost in chronic
samples (12, 13), with similar results found in FEP patients (14).
Treatment of naïve patients have shown gray matter deficits,
mainly in the fronto-temporal, thalamo-cortical, and subcortical-
limbic circuits (15, 16). There have been several attempts to
link these structural findings with the outcomes and longitudinal
trajectories of the disease, but clinical and methodological
heterogeneity limits the conclusions (17).
Conversely, little is known about longitudinal changes in FEP
during functional magnetic resonance imaging (fMRI) (18). One
review, interested in the effects of medication on chronic patients,
concluded that pharmacological antipsychotic treatments induce
functional brain alterations in the frontal regions (19), but this
conclusion has been reached by including different studies with
an enormous methodological variance.
There are some problems with performing longitudinal fMRI
studies: the cost of these techniques translates into low sample
sizes across most studies (18, 19); the experimental dropouts
in a difficult population to be recruited and evaluated; and the
methodological heterogeneity during scans, which involves many
different paradigms, usually visual or cognitive tasks (18). The
type of task is a key issue in neuroimaging, since different areas
of brain activation are shown as distinct task designs (such as
emotional, cognitive, motor, attentional, verbal) and different
sensory modalities (such as visual, auditory, resting state) are
carried out. The distinctions between the strength of the MR
scans are also noticeable, ranging from earlier studies with
1.5 T to later 7 T high field scanners, though their results are
often intermixed.
Our group developed an emotional auditory paradigm
based on some of the most common symptoms reported
by FEP patients (20, 21). Some interesting results have
been found using this method in chronic samples (22),
but the issue of longitudinal activation changes in FEP
remains unclear.
There are relatively few publications studying longitudinal
activation changes in FEP cohorts. We recently conducted
what seems to be the only systematic review about this
question and gathered the results of 13 selected studies (18).
First of all, there was a great methodological heterogeneity
across the included studies, involving different scan powers,
different intervals between scans, different regions of interest,
and different tasks and modalities. Taken together the activation
and connectivity studies, two main comparisons were carried
out. First, the patient’s group was compared with the healthy
control’s group in basal assessment, finding multiple studies with
hypoactivation in several brain areas in the patients’ group. The
most frequently hypoactivated area was the prefrontal cortex,
followed by limbic structures, occipital cortex, basal ganglia,
thalamus, hippocampus, temporal cortex, and parietal cortex.
The number of studies reporting hyperactivation in patients vs.
controls was marginal. This was in contrast to the results of
a previous selective review that concluded a hippocampal and
subcortical hyperactivation pattern in naive patients (15).
Secondly, we compared the results of the second MR
scans within the patient’s group with respect to the basal
assessment, with a general increased activation (which we
called “normalization”) in the vast majority of included studies,
especially in prefrontal cortex, basal ganglia, parietal cortex, and
occipital cortex. These results were explained in the reference
studies as treatment effects (18).
Under our emotional auditory paradigm, an important
role of amygdala in emotional processing in chronic patients
with hallucinations can be observed (20). We hypothesize
that evaluating a FEP with our emotional paradigm in fMRI
will probably show different activation patterns, especially in
amygdala, between patient and healthy control groups. We
also expect that the activation will decrease in those regions
after treatment. The purpose of this study is to compare the
longitudinal activation results evaluated with an emotional
auditory paradigm during fMRI scans in a FEP patient with
a heathy control group. The potential of this method as a
biomarker for FEP will be discussed.
MATERIALS AND METHODS
Participants
Patients were recruited from the outpatient psychiatry clinics.
People from area 5 of Valencia, who experienced psychotic
symptoms for the first time in life were submitted to the Valencia
Clinic Hospital First-Episode Unit for evaluation and treatment.
Control subjects were paired by age and educational level. All
subjects, patients and controls, were older than 18 years old
and provided written informed consent according to the Local
Ethical Committee.
There were 35 adult patients with a first F20–F29 diagnosis.
Diagnoses were based on the Structured Clinical Interview for
DSM-IV Axis I Disorders. Two weeks after their diagnosis, all
the patients underwent a semistructured interview including
sociological information and clinical scales. After the clinical
evaluation, they were proposed to be scanned with two fMRI
scans, with a minimum interval of 6 months between them.
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TABLE 1 | Sociodemographical characteristics of subjects.
FEP patients group Healthy controls group
(n = 35) (n = 13)
Age (years at first scan) 29.92 ± 8.90 35.70 ± 10.74
Gender (male/female) 28/6 8/5
Education level Illiteracy = 1 Illiteracy = 0
Primary = 9 Primary = 1
Secondary = 6 Secondary = 2
High school = 9 High school = 4
University = 10 University = 6
Work status Active = 5 Active = 9
Unemployed = 18 Unemployed = 2
Disabled = 1 Disabled = 0
Student = 11 Student = 2
Coexistence Alone = 1 Alone = 4
Origin family = 28 Origin family = 3
Own family = 2 Own family = 4
Other = 4 Other = 2
Interval (months between
scans)
25.60 ± 19.50 19.68 ± 13.03
Healthy controls were volunteers without financial
remuneration recruited from the Valencia Clinic Hospital
and Valencia University staff. They were selected after a mini
personal interview to exclude people with the following: (a)
personal or family clinical records of psychiatric illness; (b)
people who suffered from a medical illness that potentially
affected cerebral function; and (c) people who met present or
past criteria for psychoactive drug abuse or dependence (except
for tobacco). Sociodemographic data is gathered in Table 1.
Clinical Measurements
Patients were assessed by a personnel trained in FEP evaluation
(JS). Interviews were conducted during the first episode and a
few days after the start of treatment. All patients were assessed
at least twice, coinciding with the time difference between
scans. Pharmacological options were registered, even if depot
administration was implemented, and others are combinations
with non-antipsychotic medications.
The Clinical Global Impressions scale (CGI) and the Global
Assessment of Functioning scale (GAF) were taken into account
and complemented by the Positive and Negative Syndrome scale
(PANSS). The results of clinical measurements in baseline and
follow-up are summarized in Table 2.
fMRI Emotional Paradigm
An emotional auditory fMRI stimulation paradigm, designed by
our group (20, 21), was employed in this study, consisting of 13
emotional Spanish words taking into account their frequency of
presentation in the patient’s hallucinations, and 13 neutral words
with a similar number of syllables from a database (23). A set of
earphones, connected by a pair of air tubes to an external audio
player, was used. Two different fMRI acquisitions, neutral and
emotional, were conducted for each subject. The neutral words
TABLE 2 | Clinical characteristics of subjects.
Basal (n = 35) Follow-up (n = 35) p-values
CGI 4.23 ± 0.770 3.49 ± 1.040 0.002
GAF 62.20 ± 11.045 67.71 ± 15.007 0.040
PANSS: T 59.69 ± 13.809 47.17 ± 16.224 0.000
PANSS: P 15.06 ± 5.525 11.17 ± 4.914 0.002
PANSS: N 13.71 ± 4.430 11.34 ± 3.925 0.003
PANSS: PG 30.06 ± 6.708 24.17 ± 8.607 0.002











Mood stabilizers = 3
Mean CPZ equivalent
dose: 266mg. SD =
1.82
were presented first. The paradigm used a block design approach
to present the words. Four blocks of rest and four blocks of
stimulation were interleaved and presented to each participant.
Each block lasted 20 s. Subjects were informed before the MR
acquisition about the experiment and were asked to focus their
attention to the words.
MR Scanning Protocol
fMRI scans were obtained at baseline and follow-up with
a 3-T magnet (Achieva, Philips Medical Systems, Best, The
Netherlands) and a multitransmit parallel transmission
technology. Brain fMRI images were obtained using a 32-
channel head coil and a dynamic echo planar imaging (EPI)
T2∗-weighted sequence (repetition time= 2,000ms; echo time=
30ms; flip angle 90; slice thickness = 3.50mm with no interslice
gap; acquisition matrix = 128 × 128; voxel size = 1.80 × 1.80 ×
3.50mm), covering the whole brain with 40 contiguous slices.
The total fMRI acquisition duration was 160 s.
After acquisition, images were qualitatively reviewed by a
radiologist and a computer engineer, to ensure data quality.
Data was then anonymized and transferred to a workstation for
postprocessing analysis.
Analyses
Statistical Parametric Mapping version 12 software (SPM, The
Wellcome Center for Human Neuroimaging, London, UK)
and MATLAB R2015a (The MathWorks, Natick, MA, USA)
were used to process the fMRI series. First, images were
spatially realigned to minimize potential movements during the
MR acquisition. Motion maps were generated for each fMRI
series and analyzed to discard those subjects with translation
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movements (x, y, z) >1.80mm (voxel size). No subjects were
discarded after this step. Secondly, a slice timing correction was
used to adjust for temporal delays between the first and the
last slices in each fMRI dynamic. Then, a spatial normalization
algorithm was applied to normalize data with respect to a
standard template (MNI350, Montreal Neurological Institute).
Finally, the normalized images were smoothed by a 6-mm
FWHMGaussian smoothing kernel.
A first-level analysis was conducted for each individual
subject. In order to increase specificity, fMRI response was
measured during emotional words in all subjects in areas
previously reported as significant with the emotional paradigm,
including amygdala, hippocampus, cingulated gyrus, insula,
frontal, and temporal regions (21, 22, 24, 25). In these
areas, a relative measurement of functional activation [percent
signal change (PSC)] was calculated as the proportional signal
difference between the signal averaged in the rest blocks and
the signal averaged in the stimulation period was measured.
To minimize the potential effect of spurious values, a robust
strategy was used to obtain the mean and median values for each
region of interest (ROI), discarding those values with two time
differences, above or below the standard deviation of the PSC
in each area. For each ROI and case, the PSC was computed
voxel by voxel. To minimize the bias associated to multiple
statistical comparisons and to control the expected number of
false positives, a Bonferroni correction was applied at voxel level
through a family-wise error (FWE) rate correction.
A full-factorial ANOVAmodel was constructed and evaluated
to assess for changes in fMRI activation between subjects by
accounting for two main factors: clinical group (patients vs.
controls) and longitudinal acquisition (basal—MRI1 and follow-
up—MRI2).
RESULTS
fMRI Response to Emotional Stimulation
Compared with the control subjects, FEP patients showed
hyperactivated areas when the emotional stimulation was
TABLE 3 | Areas of hyperactivation in FEP patients vs. controls when emotional stimulation was applied.
MRI1 (basal) MRI2 (follow-up)
T Student Coordinates Label Brodmann T Student Coordinates Label Brodmann
9.22 [−28, 16, 58] Frontal_Mid_L 08 7.30 [−38, 40, 34] Frontal_Mid_L 46
9.02 [−12, 46, 44] Frontal_Sup_Medial_L 09
8.92 [−46, 8, 34] Frontal_Inf_Oper_L 48
8.84 [−32, 16, 34] Frontal_Inf_Oper_L 44
8.72 [−38, 16, −24] Temporal_Pole_Sup_L 38
8.49 [48, 34, −16] Frontal_Inf_Orb_R 47
Left MRI1 (basal) and right MRI2 (follow-up) (p < 0.05 FWE-corrected).
FIGURE 1 | Parametric maps showing areas of hyperactivation in FEP patients vs. controls when emotional stimulation was applied. Top row: Differences in basal
fMRI evaluation. Bottom row: Differences in follow-up fMRI evaluation (p < 0.05 FWE-corrected).
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FIGURE 2 | PSC changes over time, from basal to follow-up fMRI examination. Top row: PSC in hippocampus. Bottom row: Values in amygdala. Black lines
represent the averaged group values for FEP patients (continuous line) and healthy controls (dotted line). Colored lines represent the individual curves for patients who
increment PSC over time (blue) and those who showed a longitudinal PSC decrement (red).
applied. In the first basal fMRI acquisition, the hyperactivated
areas were located mainly at frontal and temporal regions. The
follow-up fMRI examination showed lesser differences between
FEP and healthy controls, with only a small portion of the middle
frontal lobe being hyperactivated (see Table 3 and Figure 1). A
complete list of areas, figures, and tables showing the whole-brain
full-activation maps for each group is available as Tables S1, S2
and Figures S1, S2.
Effect Over Time
FEP patients showed a significant reduction in fMRI activation
in the follow-up MRI examination of the hippocampus (F =
4.81; p= 0.03). Other areas including amygdala, cingulated gyrus,
insula, frontal, and temporal regions did not show functional
changes over time. Likewise, no significant differences were
found in healthy control subjects in these areas between both
fMRI examinations (see Figure 2 and Table 4).
Although averaged-group values in the hippocampus showed
statistically significant changes over time, a marked heterogeneity
in the behavior of the curves was detected when observing
particular subjects. While some patients showed a clear increase
of PSC activation during follow-up fMRI evaluations, others
exhibited a marked reduction over time (Figure 2).
Effect Over Clinical Groups
At baseline fMRI, FEP patients showed a significant reduction of
activation compared with controls in the amygdala (F = 4.67; p
= 0.04). By contrast temporal (F = 3.96; p= 0.04) and frontal (F
= 4.23; p = 0.04) regions were hyperactivated in FEP patients.
Other areas including the hippocampus, cingulated gyrus, and
insula did not show significant differences between groups.
In the follow-up study, both amygdala (F = 4.69; p = 0.04)
and hippocampus (F = 5.03; p= 0.03) showed a significant fMRI
reduction in patients vs. controls while the middle frontal gyrus
(F = 4.53; p = 0.04) showed a hyperactivation in patients (see
Figure 2 and Table 5).
An analysis of a possible interaction between clinical
symptoms and longitudinal changes in fMRI was made through
PANSS result data: general PANSS score, positive subscale,
negative subscale, and general psychopathology subscale. No
significant correlation between these scores and longitudinal
fMRI changes were found (Table 6).
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TABLE 4 | ANOVA showing functional PSC values of FEP patients (left) and healthy controls (right) for both, basal and follow-up fMRI evaluations.
FEP patients Healthy controls
PSC F P-value PSC F p-value
Basal (MRI1) Follow-up (MRI2) Basal (MRI1) Follow-up (MRI2)
Amygdala 7.82 (11.34) 2.70 (13.90) 1.58 0.21 12.09 (8.80) 11.75 (11.36) 0.33 0.57
Hippocampus 8.64 (8.30) −1.01 (8.79) 4.81 0.03* 6.65 (9.57) 9.83 (13.67) 0.86 0.36
Cingulated Gyrus 5.15 (19.64) 0.15 (30.15) 0.69 0.41 −0.65 (17.82) 3.28 (20.69) 0.27 0.61
Frontal 2.06 (9.48) 3.51 (10.53) 0.06 0.80 −2.40 (9.47) 0.65 (10.41) 0.28 0.60
Temporal 7.89 (7.60) 4.66 (20.79) 0.01 0.93 5.05 (7.11) 14.23 (15.56) 0.95 0.34
Insula −1.30 (19.85) 0.69 (24.85) 0.14 0.71 3.12 (12.03) 3.14 (16.84) 0.00 1.00
*p < 0.05.
TABLE 5 | ANOVA showing functional PSC values at basal (left) and follow-up (right) evaluation for FEP patients and healthy control subjects.
Basal (MRI1) Follow-up (MRI2)
PSC F p-value PSC F p-value
FEP patients Healthy controls FEP patients Healthy controls
Amygdala 7.82 (11.34) 12.09 (8.80) 4.67 0.04* 2.70 (13.90) 11.75 (11.36) 4.69 0.04*
Hippocampus 8.64 (8.30) 6.65 (9.57) 0.22 0.65 −1.01 (8.79) 9.83 (13.67) 5.03 0.03*
Cingulated gyrus 5.15 (19.64) −0.65 (17.82) 0.87 0.36 0.15 (30.15) 3.28 (20.69) 0.12 0.73
Frontal 2.06 (9.48) −2.40 (9.47) 4.23 0.04* 3.51 (10.53) 0.65 (10.41) 4.53 0.04*
Temporal 7.89 (7.60) 5.05 (7.11) 3.96 0.04* 4.66 (20.79) 14.23 (15.56) 2.27 0.14
Insula −1.30 (19.85) 3.12 (12.03) 0.57 0.46 0.69 (24.85) 3.14 (16.84) 0.11 0.74
*p < 0.05.
In order to look at the possible antipsychotic effect on fMRI,
chlorpromazine-equivalent doses were calculated and registered
(Table 2). The relationship between longitudinal activation
change and clinical variables has been calculated, showing that
there is no correlation between longitudinal fMRI changes and
antipsychotic dose (Table 6).
DISCUSSION
This first longitudinal study investigating fMRI changes in FEP
using an emotional auditory paradigm reveals an increased
activation at baseline that is reduced in follow-up. Interestingly,
in our previous systematic review of fMRI longitudinal studies
in FEP, the most common finding was just the opposite.
Patients with FEP showed at baseline a hypoactivation mainly
in PFC, basal ganglia, limbic system, hippocampus, and the
ACC, which was increased (“normalized”) after antipsychotic
treatment during follow-up (18).
The most likely explanation for understanding the differences
between our results and previous studies is the fMRI paradigm.
Most previous fMRI longitudinal studies in FEP used resting
states or different paradigms that included cognitive tasks. The
main problem of using any kind of cognitive task in psychotic
patients is the attentional bias as attentional deficits are one of
the most common findings in FEP patients (26). In fMRI studies,
these deficits correlate with general hypoactivation mainly in
the PFC (27). Moreover, hypoactivation in the PFC has been
mentioned classically as one of the most consistent findings
in chronic schizophrenia (28). However, the type of paradigm
we used in this study does not require a focus of attention or
cognitive performance but rather reflects the brain’s response to
direct emotional stimulation. In support of this, a hyperactivation
of the amygdala at baseline that decreased after treatment with
cognitive therapy was observed in schizophrenia patients with
persistent hallucinations (22).
The fact that amygdala and hippocampus showed the most
significant changes deserves an explanation. First, both areas
were the most clearly affected in our previous studies using
the same paradigm in chronic patients (29). Secondly, these
areas are implicated in the emotional response and memory,
fitting with the Kapur’s model in which the core of psychosis
could be an abnormal “salience” to external stimuli (30) or,
as more recently suggested, an abnormal connectivity between
perceptual, emotional, and memory brain areas (31).
Quite relevant is the fact that everything mentioned so
far relates with mean group variations in brain activation.
It is important to consider the great individual heterogeneity
in the results. This heterogeneity is not only in the baseline
but also in the path of brain activation changes. Some
patients show a decrease in brain activation during follow-
up, while another group presents just the opposite (Figure 2).
There are several possible explanations for these results. The
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TABLE 6 | Correlations between differences in activation in amygdala and
hippocampus and clinical variables (PANSS subscales measurements and
pharmacological treatment in chlorpromazine equivalent doses) measured as
longitudinal percentage change.
DIFAMIG DIFHIPOC PC_P PC_N PC_G
DIFAMIG
Pearson correlation 1 0.717** −0.044 0.000 0.092
Sig. (2-tailed) 0.000 0.800 0.998 0.598
N 35 35 35 35 35
DIFHIPOC
Pearson correlation 0.717** 1 −0.132 −0.041 0.117
Sig. (2-tailed) 0.000 0.451 0.813 0.503
N 35 35 35 35 35
PANSS_P
Pearson correlation −0.044 −0.132 1 0.959** 0.223
Sig. (2-tailed) 0.800 0.451 0.000 0.197
N 35 35 35 35 35
PANSS_N
Pearson correlation 0.000 −0.041 0.959** 1 0.372*
Sig. (2-tailed) 0.998 0.813 0.000 0.028
N 35 35 35 35 35
PANSS_G
Pearson correlation 0.092 0.117 0.223 0.372* 1
Sig. (2-tailed) 0.598 0.503 0.197 0.028
N 35 35 35 35 35
CPZ_EQ
Pearson correlation −0.082 −0.041 −0.067 −0.131 −0.045
Sig. (2-tailed) 0.638 0.815 0.704 0.453 0.799
N 35 35 35 35 35
*Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
simplest one is that the heterogeneity in brain activation
is due to the clinical heterogeneity of the population. Our
study sample was based on patients with first episodes of
psychosis. The first psychotic episodes can evolve very favorably
(brief reactive psychosis) or tend toward chronicity either
in a continuous deterioration or in an episodic way (32).
However, we did not find a clinical difference at baseline with
regard to the pattern of longitudinal activation changes (see
Figures S1, S2 and Tables S1, S2). That said, it is possible
to speculate that differences in brain activation are directly
related with the clinical state at the moment of fMRI. So,
the same patient could have a different degree of activation,
depending on the moment of fMRI acquisition. Moreover,
it is important to consider medication and psychosocial
interventions as important confounding variables, and it is
worth mentioning that patients were treated under naturalistic
conditions with individualized therapeutic approaches. The
results of this study showed the relevance of making an
analysis at an individual base instead of just comparing the
mean group.
This study has some limitations. Although most of the fMRI
studies involve <30 patients, it remains limiting for the field,
and this study must be interpreted wisely due to the relatively
small sample size recruited. Differences between sample sizes
in the HC and FEP groups and gender distribution should
also be taken into account. The second limitation is about
the different intervals between scans, particularly in the case
of the FEP group. As we are comparing brain function after
symptom’s onset, the natural effects of neurodevelopment should
be controlled by adjusting the time between scans. Thirdly,
although we did not find a significant correlation between
clinical symptoms and brain activation (Table 6) in our sample,
like all FEP samples, there is a great clinical heterogeneity
that it cannot be ignored. Different types of psychosis are
included, which probably involve different disease phenotypes
and, as we have shown in this paper, different pathways in
brain function. Finally, according to this clinical heterogeneity,
a wide range of pharmacological treatments appear in our
sample. Although we did not find a significant relationship
of the antipsychotic equivalent dose and fMRI activation, it
cannot be ruled out that different combinations of medications
in longitudinal studies may introduce changes in natural brain
function. More analyses are needed, studying individual cases
and possible patient subgroups [including genetic data (33)]
to improve our knowledge of brain function and the course
of psychosis.
Conversely, this study has some strengths that should be
listed. The main strength is that this is the first longitudinal
study investigating longitudinal fMRI changes in FEP samples
with an emotional auditory paradigm. Paradigm election is a key
question in neuroimaging, and there is a lack of longitudinal
studies using noncognitive task during scans. Another positive
point of this study is to incorporate clinical assessments in
addition to neuroimage acquisition data. Neuroimaging and
clinical data may be gathered to study disease course variables
in subsequent analyses.
In conclusion, we have shown that brain activation
under an emotional auditory paradigm during fMRI
scans change longitudinally in FEP patients. A significant
decrease in activation in the amygdala and hippocampus
is observed in patients compared with healthy subjects.
Still, we have also found a great clinical and activation
heterogeneity, which may reflect different pathways of
the disease.
DATA AVAILABILITY STATEMENT
The datasets presented in this article are not readily available
because of ethical restrictions. Reasonable requests to access the
datasets should be directed to Julio Sanjuan, julio.sanjuan@uv.es.
ETHICS STATEMENT
The studies involving human participants were reviewed
and approved by INCLIVA Ethical Committee. The
patients/participants provided their written informed consent to
participate in this study.
Frontiers in Psychiatry | www.frontiersin.org 7 December 2020 | Volume 11 | Article 593042
González-Vivas et al. Longitudinal fMRI First Episode Psychosis
AUTHOR CONTRIBUTIONS
JS, CG-V, GG-M, LM-B, and EA designed the study. JS
obtained the funding and supervised the study. GG-M made the
postprocessing of fMRI data. PS-M made the clinical evaluation.
RS-R made the imaging acquisition. MC-B contributed to the
data analysis. CG-V wrote the first draft of the article. JS, CG-V,
and GG-M wrote the final version. All authors contributed to the
article and approved the submitted version.
FUNDING
This study was supported by grants from the Generalitat
Valenciana (PROMETEO/2016/082, PROMETEO/2020/024),
CIBERSAM, and Carlos III Health Institute (PI13/00447;
PI17/00402) co-funded by The European Union through
FEDER funds.
ACKNOWLEDGMENTS
We sincerely thank the patients and their families
involve, as well as the nurse and technical personnel
for without them, this study would not have
been possible.
SUPPLEMENTARY MATERIAL




1. Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P,
et al. Altering the course of schizophrenia: progress and perspectives. Nat Rev
Drug Discov. (2016) 15:485–515. doi: 10.1038/nrd.2016.28
2. Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, et al.
Definition and description of schizophrenia in the DSM-5. Schizophr Res.
(2013) 150:3–10. doi: 10.1016/j.schres.2013.05.028
3. Perälä J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsä E, Pirkola S,
et al. Lifetime prevalence of psychotic and bipolar I disorders in a general
population. Arch Gen Psychiatry. (2007) 64:19. doi: 10.1001/archpsyc.6
4.1.19
4. Albert N, Weibell MA. The Outcome of Early Intervention in First Episode
Psychosis. Vol. 31, International Review of Psychiatry. Taylor and Francis
Ltd. (2019).
5. BerkM,HallamK,Malhi GS, Henry L, HastyM,Macneil C, et al. Evidence and
implications for early intervention in bipolar disorder. J Ment Heal. (2010)
19:113–26. doi: 10.3109/09638230903469111
6. Bernardo M, Cabrera B, Arango C, Bioque M, Castro-fornieles J, Lafuente
A, et al. One decade of the first episodes project (PEPs): advancing
towards a precision psychiatry Una década del proyecto de primeros
episodios (PEPs): Avanzando hacia. Rev Psiquiatr Salud Ment. (2019) 12:135–
40. doi: 10.1016/j.rpsm.2019.03.001
7. Lalevic G, Scriven M, O’Brien S. Early intervention in psychosis in the North
Lee Mental Health Services programme: a 5-year review. Ir J Psychol Med.
(2019) 36:271–7. doi: 10.1017/ipm.2019.17
8. Vieta E, Salagre E, Grande I, Carvalho AF, Fernandes BS, Berk M, et al.
Early intervention in Bipolar disorder. Am J Psychiatry. (2018) 175:411–
26. doi: 10.1176/appi.ajp.2017.17090972
9. Yung AR, Mcgorry PD, Mcfarlane CA, Jackson HJ, Patton GC, Rakkar A.
Monitoring and care of young people at incipient risk of psychosis. Schizophr
Bull. (1996) 22:283–303. doi: 10.1093/schbul/22.2.283
10. Fusar-Poli P. The clinical high-risk state for psychosis (CHR-P), Version II.
Schizophr Bull. (2017) 43:44–7. doi: 10.1093/schbul/sbw158
11. Fond G, Albis M, Jamain S, Tamouza R, Arango C, Fleischhacker
WW. The promise of biological markers for treatment response in first-
episode psychosis : a systematic review. Schizophr Bull. (2015) 41:559–
73. doi: 10.1093/schbul/sbv002
12. Wright IC, Rabe-Hesketh S, Woodruff PWR, David AS, Murray RM,
Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J
Psychiatry. (2000) 157:16–25. doi: 10.1176/ajp.157.1.16
13. Nesvåg R, Lawyer G, Varnäs K, Fjell AM, Walhovd KB, Frigessi A,
et al. Regional thinning of the cerebral cortex in schizophrenia: effects of
diagnosis, age and antipsychotic medication. Schizophr Res. (2008) 98:16–
28. doi: 10.1016/j.schres.2007.09.015
14. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA. Brain volume
in first-episode schizophrenia: systematic review and meta-analysis of
magnetic resonance imaging studies. Br J Psychiatry. (2006) 188:510–
8. doi: 10.1192/bjp.188.6.510
15. Gong Q, Lui S, Sweeney JA. A selective review of cerebral abnormalities in
patients with first-episode schizophrenia before and after treatment. Am J
Psychiatry. (2016) 173:232–43. doi: 10.1176/appi.ajp.2015.15050641
16. Davidson LL, Heinrichs RW. Quantification of frontal and temporal lobe
brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Res
Neuroimaging. (2003) 122:69–87. doi: 10.1016/S0925-4927(02)00118-X
17. Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, et al.
Magnetic resonance imaging and the prediction of outcome in first-episode
schizophrenia: a review of current evidence and directions for future research.
Schizophr Bull. (2015) 41:574–83. doi: 10.1093/schbul/sbv024
18. González-Vivas C, Soldevila-Matías P, Sparano O, García-Martí G, Martí-
Bonmatí L, Crespo-Facorro B, et al. Longitudinal studies of functional
magnetic resonance imaging in first-episode psychosis: a systematic review.
Eur Psychiatry. (2019) 59:60–9. doi: 10.1016/j.eurpsy.2019.04.009
19. Kani AS, Shinn AK, Lewandowski KE, Öngur D. Converging effects of
diverse treatment modalities on frontal cortex in schizophrenia: a review of
longitudinal functional magnetic resonance imaging studies. J Psychiatr Res.
(2017) 84:256–76. doi: 10.1016/j.jpsychires.2016.10.012
20. Sanjuán J, Lull JJ, Martí-Bonmati L, Aguilar EJ, Gadea M, Moratal-Pérez D,
et al. Emotional auditory paradigm in neuroimaging: a base for the study of
psychosis. Actas Esp Psiquiatr. (2005) 33:383–9.
21. Sanjuan J, Lull JJ, Aguilar EJ, Martí-Bonmatí L, Moratal D, Gonzalez JC,
et al. Emotional words induce enhanced brain activity in schizophrenic
patients with auditory hallucinations. Psychiatry Res Neuroimaging. (2007)
154:21–9. doi: 10.1016/j.pscychresns.2006.04.011
22. Aguilar EJ, Corripio I, García-Martí G, Grasa E, Martí-Bonmatí
L, Gómez-Ansón B, et al. Emotional fMR auditory paradigm
demonstrates normalization of limbic hyperactivity after cognitive
behavior therapy for auditory hallucinations. Schizophr Res. (2017)
193:304–12. doi: 10.1016/j.schres.2017.07.024
23. Algarabel S. Índices de interés psicolingüístico de 1917 palabras castellanas -
Dialnet. Cognitiva. (1996) 8:43–88. doi: 10.1174/021435596321235298
24. Martí-Bonmatí L, Lull JJ, Garcia-Martí G, Aguilar EJ, Moratal-Pérez D,
Poyatos C, et al. Chronic auditory hallucinations in schizophrenic patients:
MR analysis of the coincidence between functional and morphologic
abnormalities. Radiology. (2007) 244:549–56. doi: 10.1148/radiol.24420
60727
25. Garciá-Martí G, Martí-Bonmatí L, Aguilar EJ, Sanz-Requena R, Alberich-
Bayarri Á, Bonmatí A, et al. [Functional neuroimaging in the study of
aggressive behaviour in patients with schizophrenia]. Rev Neurol. (2013)
56:193–9. doi: 10.33588/rn.5604.2012627
26. Hahn B, Robinson BM, Kaiser ST, Matveeva TM, Harvey AN, Luck
SJ. Had it right: people with schizophrenia have deficits sustaining
attention over time. J Abnorm Psychol. (2012) 121:641–8. doi: 10.1037/
a0028492
Frontiers in Psychiatry | www.frontiersin.org 8 December 2020 | Volume 11 | Article 593042
González-Vivas et al. Longitudinal fMRI First Episode Psychosis
27. Del Casale A, Kotzalidis GD, Rapinesi C, Sorice S, Girardi N, Ferracuti S, et al.
Functional magnetic resonance imaging correlates of first-episode psychoses
during attentional andmemory task performance.Neuropsychobiology. (2016)
74:22–31. doi: 10.1159/000448620
28. Glahn DC, Ragland JD, Abramoff A, Barrett J, Laird AR, Bearden
CE, et al. Beyond hypofrontality: a quantitative meta- analysis
of functional neuroimaging studies of working memory in
schizophrenia. Hum Brain Mapp. (2005) 25:60–9. doi: 10.1002/hbm.
20138
29. Escartí MJ, de la Iglesia-Vayá M, Martí-Bonmatí L, Robles M, Carbonell
J, Lull JJ, et al. Increased amygdala and parahippocampal gyrus activation
in schizophrenic patients with auditory hallucinations: an fMRI study
using independent component analysis. Schizophr Res. (2010) 117:31–
41. doi: 10.1016/j.schres.2009.12.028
30. Kapur S. Psychosis as a state of aberrant salience: A framework linking biology,
phenomenology, pharmacology in schizophrenia. Am J Psychiatry. (2003)
160:13–23. doi: 10.1176/appi.ajp.160.1.13
31. Dong D, Wang Y, Chang X, Luo C, Yao D. Dysfunction of large-
scale brain networks in schizophrenia: a meta-analysis of resting-state
functional connectivity. Schizophr Bull. (2018) 1:168–18. doi: 10.1093/schbul/
sbx034
32. Santesteban-Echarri O, Paino M, Rice S, González-Blanch C, McGorry P,
Gleeson J, et al. Predictors of functional recovery in first-episode psychosis: a
systematic review and meta-analysis of longitudinal studies. Clin Psychol Rev.
(2017) 58:59–75. doi: 10.1016/j.cpr.2017.09.007
33. Sanjuán J, Castro-Martínez XH, García-Martí G, González-Fernández J, Sanz-
Requena R, Haro JM, et al. FOXP2 expression and gray matter density
in the male brains of patients with schizophrenia. Brain Imaging Behav.
(2020). doi: 10.1007/s11682-020-00339-x
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 González-Vivas, García-Martí, Soldevila-Matías, Sanz-Requena,
Aguilar, Castro-Bleda, Martí-Bonmatí and Sanjuan. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Psychiatry | www.frontiersin.org 9 December 2020 | Volume 11 | Article 593042
